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INTRODUCTION
The word stroke is used to refer to a clinical syndrome, of presumed vascular 
origin, typified by rapidly developing signs of focal or global disturbance of 
cerebral functions lasting more than 24 hours or leading to death (World Health 
Organisation 1978)33.
                                 It affects between 174 and 216 people per 100,000 
population in the UK each year (Mant et al 2004), and accounts for 11% of all 
deaths in England and Wales. Cerebral infarction accounts for 69% of strokes, 
primary haemorrhage for 13%, subarachnoid haemorrhage for 6%, and 12% are 
of uncertain type (Wolfe et al 2002). The risk of recurrent stroke within five years 
of a first stroke is between 30% and 43% (Mant et al 2004).
                                        Extravasation of blood into the brain parenchyma was 
recognized as early as 1658 by Wepfer61, although  he saw the clot as an 
obstruction of ‘vital spirits’ rather than as the disease in itself, and subsequently 
by Morgagni62. The cause remained obscure, and to a large extent it still is.77
                           We have come a long way since the time when Charcot (1881) felt 
“that  if  apoplexy was not immediately fatal,  most  survivors only retained life at  the 
expense of deplorable infirmities and perpetual confinement to bed.”
                    
With the arrival of computed tomography of the brain, diagnosis of intra-cerebral 
haemorrhage  has  been  taken  from the  age  of  calculated  speculation  with  details  of 
clinical  features,  angiograms  and  ‘bloody  taps’   to  the  present  day  of  arrival  of  a 
definitive diagnosis in a matter of minutes. A significant reason for the decreasing trend 
of mortality  in the intra-cerebral  haemorrhage patients in the industrialized countries 
have also been due to the identification of the factors which might adversely affect the 
outcome, stratifying patients and instituting prompt acute stroke care.
Though medical  management of intra-cerebral haemorrhage has been the way, 
surgical management has been known since the times of McEwen, who performed the 
first  successful  operation  for  intra-cerebral  haematoma  in  1883.  Though  no  definite 
guidelines  exist  to  decide  between  the  two  lines  of  management,  the  increasing 
availability of minimally invasive techniques like stereo-tactic aspiration may make this 
modality indispensable in the days to come.
But all is not well for a country like India, where there still exist pockets where 
CT brain is unheard of,  stroke care centers unimaginable,  and supply almost always 
short of demand. Thereby, identifying definite risk factors, designing and implementing 
policies  to  contain them,  making prompt  and accurate  diagnosis,  stratifying patients 
according to outcome predictors, and thus ensuring prompt referral of deserving critical 
patients to tertiary centers for intensive management, may be the need of the hour as we 
wait  to  embrace  the  newer  advances  into  our  management  protocols.   Intracerebral 
hemorrhage  accounts  for  approximately  10%  of  strokes  and  its  clinical  importance 
derives  from its  frequency  and accompanying high mortality.  Although the  latter  is 
strongly dependent  on HEMATOMA SIZE and to  a  lesser  extent,  LOCATION, the 
overall mortality rate varies between 25% and 60%.93  There has been a general decline 
since  the  1980s  in  the  incidence  of  stroke,  including ICH,  as  a  result  of  improved 
detection and treatment of hypertension. However, ICH continues to be a major health 
problem  especially  in  those  who  lack  hypertension  treatment  and  the  genetically 
predisposed. 
                                     A growing body of evidence suggests that genetic factors, such as 
the possession of the E2 and E4 alleles of the apolipoprotein E, play an important role in 
the occurrence of certain forms of ICH, such as lobar hemorrhages(O’Donnell et al., 
2000).98 Novel potential genetic factors predisposing to ICH continue to be added by 
experimental and clinical studies ( Gould et al., 2006).97
       Although it would appear intuitively that evacuation of a hematoma might be  
beneficial, surgical results have not been superior to those with medical measures alone 
(Waga and Yamamoto; Batjer et al; Juvela et al; Rabinstein et al). 
A  large,  multicenter,  randomized  study  involving  1,033  patients  with 
supratentorial  hemorrhage,  under  the  auspices  of  the  Surgical  Trial  in  Intracerebral 
Haemorrhage (STICH) study reported by Mendelow and colleagues, has failed to show 
a benefit from early surgery on survival or neurologic functioning at 6 months. This 
negative result extended to almost all levels of neurologic deficit and all age groups. In a 
post hoc analysis, clots that were small and close to the surface of the brain may have 
benefited from evacuation. 
As a result, this approach has been virtually abandoned, but  in a few instances 
with ongoing deterioration in young patients with hematomas that are easily accessible 
from the cortical surface, evacuation of the clot has been undertaken.3 In contrast, the 
surgical evacuation of cerebellar hematomas is a generally accepted treatment and is a 
more urgent matter because of the proximity of the mass to the brainstem and the risk of 
abrupt progression to coma and respiratory failure.3
                                                     Mayer and coworkers studied the promising approach 
of  administering  clotting  factor  VII  within  4  h  of  hemorrhage.  In  a  preliminary 
study(phase I&II), survival was improved and there was a reduction in enlargement of 
the hematoma, but their subsequent series(phase III FAST trial) has failed to confirm the 
benefit  on  survival  so  that  infusion  of  factor  VII  is  not  currently  part  of  routine 
practice  .93   Therefore,  the  surgical  management  of  ICH is  debatable  because  the 
assessment  of  potential  interventions  awaits  the  completion  of  properly  designed 
prospective clinical trials.
                                       
                                   
                                    AIMS AND OBJECTIVES
1. To  assess  clinical  profile  of  patients  with  Spontaneous  Intracerebral 
Haemorrhage.
2. To identify factors which correlate with outcome of patients with Intracerebral 
Haemorrhage including the adverse influence of alcohol and especially alcoholic 
binge within 48 hours of ictus on the mortality of patients with  Intra Cerebral 
Haemorrhage. 
3. To assess the utility of Intra Cerebral Haemorrhage Score (ICHS) and  National 
Institute  of  Health  Stroke  Scale  (  NIHSS)  in  evaluating  patients  with  Intra 
Cerebral Haemorrhage and prognoticating.
4. To  assess  the  significance  of  calculating  the  volume of  Intra  Cerebral 
Haemorrhage at various locations and their impact on the outcome and to assess 
the impact of Intra Ventricular Haemorrhage at various loations of  ICH  on the 
outcome.
                                  REVIEW OF LITERATURE
                            Intracerebral haemorrhage accounts for 10 to 15% of first time 
strokes world over1.  Incidences are predicted to be higher in Asian population2.  The 30 
day mortality ranges from 32% to 55 %2.  Of the total patients with ICH only 20 % of 
patients are expected to be functionally independent at the end of 6 months2.
Primary (Hypertensive) Intracerebral Hemorrhage
This is the mundane but often devastating "spontaneous" brain hemorrhage. It is 
predominantly a result of chronic hypertension and degenerative changes in cerebral 
arteries. In order of frequency, the most common sites of a cerebral hemorrhage are (1) 
the putamen and adjacent internal capsule (50 percent); (2) the central white matter of 
the temporal, parietal, or frontal lobes (lobar hemorrhages, not strictly associated with 
hypertension); (3) the thalamus; (4) one or the other cerebellar hemisphere; and (5) the 
pons. The vessel involved is usually a small penetrating artery that originates from a 
larger trunk vessel. Approximately 2 percent of primary hemorrhages are multiple. 
Multiple nearly simultaneous intracerebral hemorrhages raise the possibility of amyloid 
angiopathy or a bleeding diathesis  but may occur when one conventional hypertensive 
intracerebral hemorrhage causes hypertension, which in turn leads to one or more 
additional hemorrhages.3
                                        The extravasation of blood into the substance of the brain forms 
a roughly circular or oval mass that disrupts the tissue and can grow in volume if the 
bleeding continues .Adjacent brain tissue is distorted and compressed. If the hemorrhage 
is large, midline structures are displaced to the opposite side of the cranium and the 
reticular activating and respiratory centers are compromised, leading to coma and death. 
It has been long known that both the size and the location of the clot determine the 
degree of secondary brainstem compression and this was confirmed by Andrew and 
associates. Rupture or seepage of blood into the ventricular system or rarely to the 
surface subarachnoid space may occur, and the CSF becomes bloody in these cases. 
When the hemorrhage is small and located at a distance from the ventricles, the CSF 
may remain clear even on repeated examinations. In the first hours and days following 
the hemorrhage, varying degrees of edema accumulates around the clot and adds to the 
mass effect. Hydrocephalus may occur as a result of bleeding into the ventricular system 
or from compression of the third ventricle. The extravasated blood undergoes a 
predictable series of changes. At first fluid, the collection becomes a clot within hours. 
Before the clot forms, red cells settle in the dependent part of the hematoma and forms a 
meniscus with the plasma above; this is particularly prone to occur in cases of 
anticoagulant-induced hemorrhage. The resultant fluid level can be observed on CT scan 
and MRI ("hematocrit effect"). Hematomas, when examined in autopsy material, contain 
only masses of red blood cells and proteins; rarely one sees a few remnants of destroyed 
brain tissue. The hematoma is often surrounded by petechial hemorrhages from torn 
arterioles and venules. 
                                                         Within a few days, hemoglobin products, mainly 
hemosiderin and hematoidin, begin to appear. The hemosiderin forms within histiocytes 
that have phagocytized red blood cells (RBCs) and takes the form of ferritin granules 
that stain positively for iron. As oxyhemoglobin is liberated from the RBCs and 
becomes deoxygenated, methemoglobin appears. This begins within a few days and 
imparts a brownish hue to the periphery of the clot. Phagocytosis of red cells begins 
within 24 h, and hemosiderin is first observed around the margins of the clot in 5 to 6 
days. The clot changes color gradually over a few weeks from dark red to pale red, and 
the border of golden-brown hemosiderin widens. The edema disappears over many days 
or weeks. In 2 to 3 months, larger clots are filled with a chrome-colored thick fluid, 
which is slowly absorbed, leaving a smooth-walled cavity or a yellow-brown scar. The 
iron pigment (hematin) becomes dispersed and studs adjacent astrocytes and neurons 
and may persist well beyond the border of the hemorrhage for years.3
                                                   Imaging techniques demonstrate a predictable sequence 
of changes. In CT scans, fresh blood is visualized as a white mass as soon as it is shed. 
The mass effect and the surrounding extruded serum and edema are hypodense. After 2 
to 3 weeks, the surrounding edema begins to recede and the density of the hematoma 
decreases, first at the periphery. Gradually the clot becomes isodense with brain. There 
may be a ring of enhancement from the hemosiderin-filled macrophages and the reacting 
cells that form a capsule for the hemorrhage. 
                                           At one point several weeks after the bleed, the appearance 
may transiently simulate a tumor or abscess. By MRI, either in conventional T1- or T2-
weighted images, the hemorrhage is not easily visible in the 2 or 3 days after bleeding, 
as oxyhemoglobin is diamagnetic or, at most, is slightly hypointense, so that only the 
mass effect is evident. MR gradient-echo images that display areas of magnetic 
susceptibility will show hemorrhages earlier and detect remnants of deposited 
hemosiderin even years afterwards.3
                                         After several days the surrounding edema is hyperintense in T2-weighted 
images. As deoxyhemoglobin and methemoglobin form, the hematoma signal becomes 
bright on T1-weighted images and dark on T2. As the hematoma becomes subacute, the 
dark images gradually brighten. When methemoglobin disappears and only hemosiderin 
remains, the entire remaining mass is hypodense on T2-weighted images, as are the 
surrounding deposits of iron. The sizes of cerebral hemorrhages vary widely. Massive 
refers to hemorrhages several centimeters in diameter; small applies to those 1 to 2 cm 
in diameter and less than 20 mL in volume. The volume and location relate to outcome 
and the nature of the initial neurologic deficit3.
Risk Factors
                     There has been a rapid and remarkable 60% decline in death rates from 
stroke in the United States, and in most of the industrialized countries since 19725. 
 In addition, there is a striking decline in the incidence of intra-cerebral haemorrhage in 
Sweden8.  This declining trend in case fatality rate of stroke in most industrialized 
countries may be explained by 3 mechanisms. 
                                          1.Improved acute stroke care which has prolonged survival. 
2.Stroke cases in these places are  less severe3. Stroke cases that were mild in severity 
and previously undetected are being detected now9.
               This data serves to highlight the operation of environmental influences that are 
amenable to modification, and the intensity of effort and optimal utilization of public 
health resources to implement preventive measures might be the way for developing 
countries like India to deal with stroke. This journey begins with assessing the changing 
risk factors which might predispose our population to the dise Untreated or under-
treated hypertension is the single most important risk factor for spontaneous 
intracerebral haemorrhage (ICH)3.   
                                              Spontaneous intracerebral haemorrhage is considered to be 
predominantly a direct effect of chronic hypertension and the degenerative changes in 
the cerebral arteries3 Advanced age and heavy alcohol consumption are also known to 
be risk factors for ICH2. 
Pathogenesis   
                         Sustained hypertension induces smooth muscle cell proliferation in the 
arterioles. This process is  termed hyper plastic arteriolo sclerosis42. Over time, smooth 
muscle cells die and the tunica media is replaced by collagen, resulting in vessels with 
decreased  tone and poor compliance. The arterioles ultimately undergo ectasia and 
aneurysmal dilation42. These micro aneurysms, called Charcot-Bouchard aneurysms, are 
susceptible to rupture leading to cerebral hemorrhage and were proposed by Charcot and 
Bouchard in 1868 as a key element of deep ICH43,44.45.  These aneurysms, occur in 
vessels that are less than 300 micro meter in diameter, most commonly in the basal 
ganglia, thereby making this the most common location of bleed4. However in few of the 
haemorrhages examined at autopsy with serial sections by C M fisher, the bleeding 
could not be traced to the aforementioned aneurysms3. 
Takebayaschi and co workers, in an electron microscopy study, found breaks in 
the elastic lamina at multiple sites, almost always at the bifurcation of the small vessels. 
Possibly these represent sites of secondary rupture from tearing of small vessels by the 
expanding hematoma.3  The extravasated blood forms an oval  mass  that  disrupts  and 
compresses the adjacent tissue as it grows in volume. 
                                                                     If the haemorrhage is large, midline  
structures are displaced to the opposite side and the reticular activating and respiratory 
centers can be compromised, leading to coma and death. 
       In the first hours and days following the haemorrhage, a limited amount of 
oedema accumulates around the clot and adds to the mass effect. Hydrocephalus may 
occur as a result of bleeding into the ventricular system or from compression of the third 
ventricle3.
Clinical features 
                                             Of all the cerebrovascular diseases, brain hemorrhage is the 
most dramatic and from ancient times has been given its own name, "apoplexy." The 
prototype is an obese, plethoric, hypertensive male who falls senseless to the ground—
impervious to shouts, shaking, and pinching—breathes stertorously, and dies in a few 
hours. A massive blood clot escapes from the brain as it is removed postmortem. With 
smaller hemorrhages, the clinical picture conforms more closely to the usual temporal 
profile of a stroke, i.e., an abrupt onset of symptoms that evolve gradually and steadily 
over minutes or hours, depending on the size of the ruptured artery and the speed and 
expansion of bleeding3.
                           Perihematomal  edema volume increases by approximately 75% during 
the first 24 hours after spontaneous ICH and has been implicated in the delayed mass 
effect that occurs in the second and third weeks after ICH55,56.
                           
                                                                  The clinical presentation of ICH had two main 
elements : symptoms that reflect the effects of intracranial hypertension and those that 
are specific for the  location  of  the  haematoma.The   general  clinical manifestations 
related to ICP are headache, vomiting,  depressed level of consciousness, which vary in 
their frequency.93
                       A few clinical features which occur with a greater frequency in patients 
with intra-cerebral haemorrhage need special mention. 
Acute reactive hypertension, far exceeding the patient’s   chronic hypertensive level, is 
a feature that should always   suggest haemorrhage; it is seen with moderate and large 
clots   situated in deep regions. Vomiting at the onset of intra-cerebral haemorrhage 
occurs  much  more  frequently  than  with  infarction  and  should  always  suggest 
haemorrhage as the cause of an acute hemiparesis.
                                                    Severe headache  is generally considered to be an 
accompaniment  of  intra-cerebral  haemorrhage,  but  in  almost  50  percent  of  cases 
headache has been absent  or  mild in degree  Loss of  consciousness is  more often a 
feature  of  haemorrhage  than  infarct,  though  a  significant  number  of  haemorrhagic 
patients are alert at presentation.  Seizures, usually focal, occur in the first few days in 
some 10 percent of cases of supratentorial haemorrhage, but more  commonly  as a 
delayed event, months or even years after the event. 
                                                             Most of the haemorrhages develop over 30 – 90  
minutes.2  Thereby  the  patient  might  develop  headache  or  vomiting,   followed   by 
sagging of the face in the next few minutes, followed by slurring of speech and then 
notice  the  arms  and  legs  gradually  weakening3. In  the  majority  of  cases,  the 
haemorrhage has its onset while the patient is up and active; onset during sleep is a 
rarity.  However,  haemorrhages  may  occur  when  the  patient  is  calm and  unstressed 
(Caplan, 1993). 
Headache, acute hypertension, and vomiting with a focal neurologic deficit are 
therefore the cardinal features and serve most dependably to distinguish haemorrhage 
from ischemic stroke. Having said that, it must be noted that these prodromal symptoms 
do not occur with any consistency3. 
Types of intracerebral haemorrhage:
Putaminal  haemorrhage
                             This is the most common site of hypertensive bleed, and the adjacent 
internal capsule is usually damaged. Contralateral hemiparesis is therefore the sentinel 
sign. When haemorrhage is large, drowsiness gives way to coma, a dilated pupil and 
fixed ipsilateral pupil, and decerebrate rigidity.  
Thalamic haemorrhages      
                                 They produce a contralateral hemiparesis due to extension into the 
adjacent  internal  capsule.  A  prominent  sensory  deficit  involving  all  the  sensory 
modalities is usually present.  Thalamic haemorrhage, by virtue of its extension into the 
subthalamus and high midbrain, may cause a series of ocular disturbances. 
Pontine haemorrhages
                                        Here deep coma usually ensues in a few minutes, and the 
clinical picture is dominated by total paralysis, decerebrate rigidity, and small   (1-mm) 
pupils that react to light. Lateral eye movements, evoked by head turning or caloric 
testing, are impaired or absent. Death usually occurs within a few hours, but there are 
rare exceptions in which consciousness  is retained and the clinical manifestations 
indicate a smaller lesion in the tegmentum of the pons. 
Cerebellar Haemorrhage 
                                        Repeated vomiting is a prominent feature, along with occipital 
headache, vertigo, and inability to sit, stand, or walk. In the early phase of the illness, 
other clinical signs of cerebellar disease may be minimal or lacking; only a minority of 
cases show nystagmus or cerebellar ataxia of the limbs, although these signs must 
always be sought. Dysarthria and dysphagia may be prominent in some cases but usually 
absent. In the series collected by St. Louis and colleagues, patients with vermian clots 
and hydrocephalus were at the highest risk for rapid deterioration. As the hours pass, and 
occasionally with unanticipated suddenness, the patient becomes stuporous and then 
comatose or suddenly apneic as a result of brainstem compression, at which point 
reversal of the syndrome, even by surgical therapy, is seldom successful.3
Caudate haemorrhage
                                                 The most common clinical presentations are severe 
headache, nausea, vomiting, and signs of marked meningeal irritation, mimicking a SAH 
or primary IVH.These patients show no prominent motor, sensory, or visual 
abnormalities (Pedrazzi et al 1990).The parenchymal haemaatoma itself does not require 
surgical intervention but emergency extraventricular drainage may be required when 
acute hydrocephalus develops.However, a permanent VPShunt is necessary only 
rarely.76
Lobar Hemorrhage
                                              Bleeding in areas other than those listed above, specifically 
in the subcortical white matter of one of the lobes of the cerebral hemisphere, is not 
associated strictly with hypertension. Any number of other causes are usually 
responsible, the main ones being anticoagulation or thrombolytic therapy, acquired 
coagulopathies, cranial trauma, arteriovenous malformation , trauma, and, in the elderly, 
amyloidosis of the cerebral vessels.In one series of  26 patients with lobar ICH, 14 had 
normal blood pressure, and in several of the fatal cases there was amyloidosis of the 
affected vessels; 2 patients were receiving anticoagulants, 2 had an arteriovenous 
malformation, and 1 had a metastatic tumor. Similarly, in the series of 22 patients with 
lobar clots reported by Kase and colleagues, 55 percent were normotensive; metastatic 
tumors, arteriovenous malformations, and blood dyscrasias were found in 14, 9, and 5 
percent of the patients, respectively. Amyloid angiopathy is an important cause of   lobar 
hemorrhage in the elderly patients
 Course and Prognosis
                         The immediate prognosis for large and medium-sized cerebral clots is 
grave; some 30 to 35 percent of patients die in 1 to 30 days. In these cases, either the 
hemorrhage has extended into the ventricular system or intracranial pressure becomes 
elevated to levels that preclude normal perfusion of the brain. Or the hemorrhage seeps 
into vital centers such as the hypothalamus or midbrain.3
                                          A formula that predicts outcome of hemorrhage based on clot 
size was devised by Broderick and coworkers; it is mainly applicable to putaminal and 
thalamic clots. A volume of  30 mL  or less, calculated by various methods from the CT 
scan predicted a generally favorable outcome; only 1 of their 71 patients with clots 
larger than 30 mL had regained independent function by 1 month. By contrast,  in 
patients with clots of 60 mL or larger and an initial Glasgow Coma Scale score of 8 or 
less, the mortality was 90 percent . 
   As remarked earlier, it is the location of the hematoma, not simply its size that 
determines the clinical effects. A clot 60 mL in volume is almost uniformly fatal if 
situated in the basal ganglia but may allow reasonably good outcome if located in the 
frontal or occipital lobe. From the studies of Diringer and colleagues (1998), 
hydrocephalus is also an important predictor of poor outcome.3
 Predictors of Outcome
Intra-cerebral haemorrhage has been known as the stroke subtype with the highest case 
fatality rates from time immemorial.7 
                            To identify the patients with a potential worse outcome would enable 
the treating team to anticipate and triage patients for stratifying care and prognosticate 
for the sake of clinical research and explaining the situation to the family.    Numerous 
parameters have been identified, some with consistent results in predicting outcomes, 
and others not so.
Age
               Age has been reported to be a significant independent outcome predictor in 
some 13,14 but not the majority of previous studies. Age may appear important for several 
reasons. Younger patients tend to present to hospital sooner after ictus13; although no 
specific  therapy  has  been  demonstrated  to  have  a  significant effect  on  outcome  in 
controlled trials, earlier treatment may reduce mortality.
Second, the elderly, may not receive life-sustaining treatment as aggressive as that 
given to  younger  patients.  Finally,  age  may serve  as a proxy for  other  inter-current 
illnesses that might complicate the clinical situation.
Glasgow Coma Scale
The  Glasgow  Coma  Scale  (GCS)  measures  the  best  eye,  motor and  verbal 
responses, and is a widely used and accepted prognostic score for both traumatic and 
non-traumatic altered consciousness levels18. The score has been validated for its inter-
observer  reliability.19 
The assessment of consciousness level in acute stroke is important for clinical 
management and as an indicator of prognosis.  As stroke may cause localized motor, 
speech or language deficits, the accuracy of the GCS as a measure of consciousness level 
may be affected. In turn, its’ prognostic value may be impaired. 
Weir  et  al  found  that dysphasic  subgroup  showed  that  the  verbal component 
provided additional  prognostic  information  to  the combined  eye  and  motor  scores17. 
When a language disorder is absent, the verbal score contributes prognostic information 
by measuring level of consciousness or by acting as a marker for confusion17.  Thereby, 
the GCS score might retain independent outcome predictor value in stroke patients, its 
utility is increased if combined with the other stroke predictors17.   
The National Institutes of Health Stroke Scale (NIHSS)   
             
                                                      The NIHSS is a 15-item neurologic examination stroke 
scale used to evaluate the effect of acute stroke on the levels of consciousness, language, 
neglect, visual-field loss, extraocular movement, motor strength, ataxia, dysarthria, and 
sensory  loss  and thereby quantitate  accurately  the  neurological  deficit.   There  is  an 
allowance for untestable items 28. The scale is widely used as a clinical assessment tool 
to evaluate acuity of stroke patients, determine appropriate treatment, and predict patient 
outcome29.
Computed tomography findings
With  the  advent  of  CT scanning,  estimations  of  the  volume  of  intra-cerebral 
haemorrhages were possible which lead to numerous studies, which confirmed a positive 
correlation between increasing volume of bleed and worsening outcome22,27. Kothari et 
al then went to on devise a simple technique to estimate the volume of bleed by using 
the formula for volume estimation of an ellipsoid24.  The volume as estimated by the 
above technique has been validated to be accurate and quick to use23. Expansion of the 
haematoma as a complication has been noted to have a graver prognosis25
Tuhrim S et  al  noted that  intra-ventricular  extension of  a  bleed  in  a  supra-
tentorial  location  was  associated  with  worsening  of  prognosis27.   This  finding  was 
confirmed by a few other studies as an independent predictor of outcome15. 
       Infra-tentorial location of the bleed has been identified as a potential 
predictor of poor outcome, due to the increased chances of obstructive hydrocephalus 
and brainstem involvement17,26.
Outcome predictor scores
Most of  these independent  variables which predicted outcome in ICH patients 
were noted to have greater significance of correlation on combination as assessed by 
multivariate analysis. This led to formulation and validation of a series of scores with 
varying permutations of the above mentioned variables. One of the earliest and one that 
has stood the test of time is the Intra-Cerebral Haemorrhage(ICH) score as conceived 
by    J Claude Hemophill et al15.
Based  on  the  strength of  independent  association  of  the  specified  parameters, 
points were assigned and a stratification scale designed.  The total ICH Score ranges 
from 0 to 5 and the 30 day mortality of each of the scores was found to have a linear 
correlation with the score15.
A number of studies following this study have validated the score including the 
one by Fernandes30 et al, Cheung et al32 and Ruiz Sandovol et al31. 
                                 
                                        MATERIALS AND METHODS
Setting : In-patients,
                   Government General Hospital, 
                   Madras Medical College, Chennai.
Ethical committee : Obtained 
Approval
Design of study :  Single center,  descriptive study 
Period of study :   August 2006 – March 2009.
Sample size :         231 patients.
                              Selection of study subjects
Inclusion criteria:       
Patients with Spontaneous 
                                  Intracerebral Haemorrhage.
Exclusion criteria   : 
            
                                 Traumatic ICH
                                  Haemorrhagic infarcts
                                  AVM and aneurysmal ICH
                                  Primary IVH
 Methodology :
The study was carried out in the wards of  Government General Hospital.
Patients  with  Spontaneous  Intracerebral  Haemorrhage  as  confirmed  by  computed 
tomography of the brain were selected.  A total of 231 patients were included as per the 
selection criteria. They were enrolled into the study after informed consent was obtained 
from the patients and from the closest relative in case of patients in altered sensorium.
                       Patients’ demographic, social, economic and medical details were 
recorded  in  the  proforma  sheet.  Information  regarding  the  symptoms  preceding  the 
present illness were recorded as well. 
The  initial  assessment  on  admission  included  assessment  of  level  of 
consciousness using the  Glasgow Coma Scale (GCS),  blood pressure measurement, 
neurological deficit assessment using  the National Institute of Health Stroke Scale 
(NIHSS) .
                                  The Intra Cerebral Haemorrhage (ICH) Score  was calculated, 
and  the  Guy Allen  score  was  calculated  24  hours  after  admission  to  differentiate 
patients into the subtypes of strokes.
Computed Tomography (CT) Scanning of the Brain was studied to record the 
location of the bleed, presence of intraventricular extension. The volume of the bleed 
was calculated using the ABC/2 technique. 
In the bedside ABC/2 method, the CT slice with the largest area of haemorrhage 
was identified. The largest diameter (A) of the haemorrhage on this slice was measured. 
The largest diameter 90 degrees to A on the same slice was measured next (B). Finally, 
the approximate number of 10-mm slices on which the ICH were seen was calculated 
(C). C was calculated by a comparison of each CT slice with haemorrhage to the CT 
slice with the largest haemorrhage on that scan. If the haemorrhage area for a particular 
slice was greater than 75% of the area seen on the slice where the haemorrhage was 
largest, the slice was considered 1 haemorrhage slice for determining C.  If the area was 
approximately 25% to 75% of the area, the slice was considered half a haemorrhage 
slice; and if the area was less than 25% of the largest haemorrhage, the slice was not 
considered a haemorrhage slice. These CT haemorrhage slice values were then added to 
determine the value for C. All measurements for A and B were made with the use of the 
centimeter scale on the CT scan to the nearest 0.5 cm. A, B, and C were then multiplied 
and  the  product  divided  by  2,  which  yielded  the  volume  of  haemorrhage  in  cubic 
centimeters (ml). Outcome was evaluated on the 30th  day of discharge (or earlier in case 
of death)  and functional  disability graded using the  Modified Rankin Scale (mRS). 
This score assesses functional independence and impact on activities in daily living and 
grades patients from 0 (no symptoms) to 6  (death). 
                                      
                                       RESULTS
 Total no. of patients  -- 231
Sex :
       Male        --  162  (70.1%)
       Female    --   69   (29.8%)  
Age group (years) :
     20 – 40     --  39   (16.8%)
     40 – 60    --   102 (44.1%)
     60 – 80    --   87    (37.6%)
      > 80       --   3       (1.2%)
Arrival time in EMD after ictus :
     ½ hr                  --- 0    (0%)
    1—2 hrs             --- 3    (1.2%)
    2—3 hrs             --- 21  ( 9.09 %)
    3—6 hrs             --- 57  (24.6%)
    6—12hrs            --- 36  (15.5%)
    12—24 hrs         --- 30  (12.9%)
    24—48 hrs         --- 30  (12.95)
    After 2 days       --- 54  (23.3%)
Educational status :
     Primary school           -- 39   (16.8%)
     Sec.school                  -- 63   (27.2%)
     U.G                            --  21   (9.09%)
     P.G                             --  3     (1.29%)
     Professional               --  0      (0%)
     Uneducated               --   105 (45.4%)
Religion :
    Hindu        --  195  (84.4%)
    Muslim     --  18    (7.79%)
    Christian  --   18    (7.79%)
    Others      --   0      (0%) 
    H/O  DM               --  36   (15.5%)
    H/O  HT                --  99   (42.8%)
    Smoking                --  66   ( 28.5%)
    Alcoholism           --   108  (46.7%)
    Alcohol 
    consumption
    within 48hrs         --   75     (32.4%)
    symptoms at onset :
    Headache              --  102    (44.1%)
    Vomiting              --   129    (55.8%)
    Headache &
    Vomiting              --   81      (35.1%)
    LOC                     --   120    (51.9%)
    Seizure                 --   30      (12.9%)
   Limb weakness    --    186    (80.5%)
   Speech disturb     --    132    (57.1%)
   Sensory loss        --     27     (11.6%)
   Visual disturb      --    30      (12.9%)
Activity when symptoms noticed first :
    Sleep                  --     18   (7.79%)
   On awakening    --     9     (3.89%)
   While rest          --     60    (25.9%0
   Light activity    --      126  (54.5%)
  Heavy exertion   --     18    (7.79%)
   Diastolic BP(mm Hg) on admission :
     <  80                 --   6   (2.59%)
    80 – 90              --   42  (18.1%)
    91 – 100            --   69  (29.8%)
    101 – 110          --   63  (27.2%)
    111 – 120          --   27  (11.6%)
    121 – 130         --   6     (2.59%)
     >130                --   18   (7.79%)
Systolic BP(mm Hg) on admission :
    < 120                 --  12   (5.19%)
    120 – 140          --   30    (12.9%)
    141 – 160          --   39  (16.8%)
    161 – 180          --   54  (23.4%)
    181 –200           --   45 ( 19.5%)
    201 – 220          --   21  (9.07%)
    > 220                 --   30  (12.9%)
NIHSS :
   Mild            --  </= 6          --  54 (23%)
Moderate        --  7—10        --  21 (9.1%)
Moderately 
Severe            --   11 – 15      --  30  (12.9%)
Severe            --   16 – 22      --  57  (25%)
Very severe   --    >/= 23       --  69   (29.9%)
mRS :
    1    --    15 (6.49%)
    2   --     3    (1.29%)
    3   --    12   ( 5.19%)
    4   --    48   (20.7%)
    5   --    153 (66.2%)
ICH location :
    Putamen                   -- 126  (54.5%)
    Thalamus                  --  60    (25.9)
    Pons                          --  12    ( 5.19%)
    Cerebellum               --   9     ( 3.89%)
    Lobar                        --   18    (7.79%)
    Caudate nucleus       --  6     ( 2.59 %)
VOLUME OF ICH ;
Putamen 
Total no.of pts :126
< 5ml                 --   21(16.6%)
5-10ml               --   18(14.2%)
11-20 ml            --   15(11.9%)
21-30 ml            --  18(14.2%)
31-40 ml            --  6(4.76%)
41-50 ml            --  24(19.04%)
51-60 ml            --  6(4.76%)
61-70 ml            --  9(7.14%)
71-100 ml          -- 3(2.38%)
>101 ml             -- 6(4.76%)
Thalamus 
Total no. of pts :60 
<2 ml                 --  15(25%)
2-5 ml                --  12(20%)                
6-10 ml              --  12(20%)
11-20 ml            --  15(25%)
>20 ml               --  6(10%)
Pons
Total no. of pts :12
<2 ml                --  3(25%)
2-5 ml               --  3(25%)
6-20 ml             --  3(25%)
>20 ml              --  3(25%
Cerebellum 
Total no. of pts : 9
<10 ml               --  3(34%)
10-20 ml            --  6(66%)
Lobar hge 
Total no. of pts : 18
<10 ml               --  6(33.3%)
10-20 ml            --  6(33.3%)
>20 ml               --  6(33.3%)
Caudate hge
Total no. of pts : 6
<5 ml                 --  3(50%)
5-10 ml              --  3(50%)
IVH                                                                 Overall incidence       
   
Total no. of pts: 102                                   --           44.1%
IVH in putaminal hge   --  48(38.1%)        --           47.1%
IVH in thalamic hge     --  36(60%)           --            35.2%
IVH in pontine hge       --  3(25%)             --           2.9%
IVH in cerebellar ICH  --  6(66.7%)          --           5.8%
IVH in lobar hge          --   3(16.7%)         --            2.94%         
IVH in caudate Hge     --   6(100%)           --           5.8%
Guy’s Allen score
<15                               --  39(16.88%)
16.40 --  75(32.46%)
41.60 --  93(40.25%)
>60                               --  24(10.38%)
    Outcome at 1 month (mRS)
0 --  9(3.89%)
1 --  15(6.49%)
2 --  3(1.29%)
3 --  42(18.8%)
4 --  18(7.79%)
5 --  87(37.6%)
6 --  57(24.6%)
Alcohol consumption within 48hrs of Ictus and death
No. of of pts who consumed alcohol within    
                            72 hrs preceding the ictus          --  75 (32.5%)
No. of pts who died in the study                             --  57 (24.7%)
No. of pts who consumed alcohol within
      72 hrs preceding the ictus among those 
                                                      who died          --  27 (47.4%)
Alcohol consumption within 48hrs of Ictus and good outcome
Total no. of patients with 
                   good outcome( mRS</= 3)               -- 69 (30%)
Among the patients with good outcome, 
    those who consumed alcohol within 
        72 hrs of the ictus                                       -- 21 (30%)
Among the patients with good outcome, 
    those who did not consume alcohol within 
        72 hrs of the ictus                                       -- 48 (70% )
 
                                         
                                               Table 1
Outcome of patients with putaminal ICH with respect to volume
                                                    N=126
volume mRS
 0 1 2 3 4 5 6
<5 ml 6 9  3 3 6  
5-10 ml    3 6 6  
11-20 ml  3  3  6  
21-30 ml      12 6
31-40 ml      3 3
41-50 ml      18 6
51-60 ml      3 3
61-70 ml      3 6
71-100 ml       3
>101 ml       6
   
                                          Table 2
Outcome of patients with thalamic ICH with respect to volume
                                                    N=60
volume mRS
 0 1 2 3 4 5 6
<2 ml  3  9  3  
2-5 ml    9 3   
6-10 ml    3 3 6  
11-20 ml      9 6
>20 ml      6  
                           
                                       Table 3
Outcome of patients with pontine ICH with respect to volume
                                             N=12
volume mRS
 0 1 2 3 4 5 6
<2 ml    3    
2-5 ml    3    
6-20 ml       3
>20 ml       3
                                               
                                              Table 4
Outcome of patients with cerebellar ICH with respect to volume
                                                         N=9
volume mRS
 0 1 2 3 4 5 6
<10ml   3     
10 - 20 ml       6
                                          Table 5
Outcome of patients with lobar ICH with respect to volume
                                                        N=18
volume mRS
 0 1 2 3 4 5 6
<10 ml    3              3
10-20 ml    3 3   
>20 ml      3 3
                                           Table 6
Outcome of patients with caudate ICH volume with respect tovolume 
                                            N = 6                                                    
volume mRS
 0 1 2 3 4 5 6
<5ml 3       
5 – 10ml      3  
                      
                                                Table 7
Outcome of patients with putaminal hge with respect to IVH
                                                          N = 126
mRs
 0 1 2 3 4 5 6
pts with IVH      24 24
pts without 
IVH
6 12  9 9 33 9
                                                   Table 8
Outcome of patients with thalamic hge with respect to IVH
                                                                    N = 60
mRS
 0 1 2 3 4 5 6
pts with IVH     6 24 6
pts with out 
IVH
 3  18   3
                          
                                                  Table 9
Outcome of patients with pontine hge with respect to IVH
                                                            N = 12
 mRS
 0 1 2 3 4 5 6
pts with IVH       3
pts with out 
IVH
   6   3
                                        Table 10
Outcome of patients with cerebellar hge with respect to IVH
                                                 N = 9
mRS
 0 1 2 3 4 5 6
pts with IVH       6
pts without 
IVH
  3     
                                             Table 11
Outcome of patients with lobar hge with respect to IVH
                                                   N = 18
mRS
 0 1 2 3 4 5 6
pts with IVH    3    
pts without 
IVH
  3 3 3 6
                                                 Table 12
Outcome of patients with caudate hge  with respect to IVH
                                                                N = 6
mRS
 0 1 2 3 4 5 6
pts with IVH 3     3  
pts with out 
IVH
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                                                DISCUSSION
                                                     Among the 231 patients enrolled, male patients 
constituted 162 (70.1%) and female patients 69 (29.8%) making up a male :female ratio 
of 5:2.Similarly, in the study of brain herniations in  ICH,conducted at 
SGPGIMS,Lucknow,out of  24 patients, 18( 75% ) were men and only 6( 25% ) were 
women,indicating a similar male preponderence.86 In  general spontaneous intracerebral 
haemorrhage  occurs more commonly in men than women(Fewel et al).78The influence 
of gender is unclear, with various investigators reporting a higher incidence in women 
( Matsumoto et al,AbuZied et al, Robins et al ) or in men 
( Barucha et al, Waga et al, Kunitz et al ).89 If the reason for the significantly higher 
proportion of male patients with ICH in our study  is analysed it can be understood that 
the most important contributing factor is alcoholism prevalent among males . The 
overall incidence of alcoholism is 46.7% and among the 162 males, 108 gave h/o 
alcoholism and of whom 75 had consumed alcohol within 48hrs of the ictus.
                      From previous studies (Gupta S.P. et al) it is obvious that in India the 
prevalence of hypertension in males and females respectively is 59.9 and 69.9 per 1000 
in urban population and 35.5 and 35.9 per 1000 in rural population.80 In the developed 
countries, the normal ratio of hypertension frequency in women versus men increases 
from 0.6 to 0.7 at age 30 to1.1 to 1.2 at age 65 and the environmental factors implicated 
in the development of hypertension with increasing age like salt intake, obesity, 
occupation, family size, crowding and alcohol intake have importance only in more 
affluent societies. In our study most of the patients are from less affluent societies.
                              The study by Kearney et al suggested that men and women have 
similar overall prevalence of  hypertension all over the world.79  Therefore the 
prevalence of hypertension among either sex is not the reason for increased incidence of 
ICH in males but it is the prevalence of alcoholism among males that makes them more 
susceptible to ICH. This implies that statutory measures have to be taken to curb the 
habit of consuming alcoholic beverages by Indians. 
                    ICH is rare before the age of 45 years and becomes increasingly more 
frequent with advancing age.89 Age greater than 65 years is associated with an odds ratio 
of 2.8 for recurrence of ICH.Although age cannot be treated, this is useful prognostic 
information for patients and their health care providers.74 On analysing the age group of 
patients it is seen that the incidence after 80 years is only about 1% which probably 
reflects the lower life expectancy of people in this part of the world. Among the rest of 
the patients only 16.8% of them are below the age of 40 yrs.These factors are 
concordant with the previous observation that advancing age and heavy alcohol 
consumption increase the risk of ICH.64,65
                   In 2005, Mayer and colleagues published the results of a phase 2 B trial 
using recombinant activated factor VII (rFVIIa) acutely to manage noncongulopathic 
ICH. This dose – finding study included 399 subjects allocated to 40,80, or 160 mg/kg 
or rFVIIa within 4 hrs of symptom onset and within 1hr from the baseline CT scan. The 
primary outcome was haematoma growth at 24hrs and the reduction in volume was 
statistically significant only for the highest dosage. There was no effect on haematoma 
enlargement among those treated more than 3hrs after symptom onset. Mortality and the 
combined outcome of death or severe disability were significantly reduced in patients 
treated with rVIIa.67 The current USFDA label  indication for rFVIIa is haemophilia 
with factor inhibitions and bleeding emergencies. Though rFVIIa does not hold an FDA 
indication for use in management of ICH at present, the recommendations may likely 
change in the near future in which case the most important pre requisite will be the time 
of arrival of the patient to the hospital being less than 3hrs. In our study it can be seen 
only 10% of patients had arrived within 3hrs to the EMD, a figure which needs to be 
substantially improved through health education and creation of awareness among  the 
public regarding the early arrival to the hospital. Even at 6hrs, only 35% of the patients 
had arrived which reflects the various factors associated  with failure of patients to arrive 
earlier like lack of awareness, lack of access to transport facilities at the earliest, delay in 
local clinics, poverty and so on.
                 Analysing the educational status of the patient population it can be seen that 
about 45% of patients are uneducated with only additional 17% having completed 
primary school and professionals being 0%. This probably reflects the fact that more 
educated people in the higher socio economic  stratum get their risk factors like 
hypertension well controlled and in case of emergency seek treatment at  non 
government institutions.
               The analysis of religious background of patients shows that about 84% of them 
belong to Hindu community with 8% each from Muslim and Christian communities 
which probably is a reflection of the distribution of various religions in this part of the 
country and  not the incidence of ICH in these communities.
           The prevalence of hypertension has been found to rise in the recent years 
globally.Kearney et al., pooled data from different regions of the world to estimate the 
overall burden of hypertension.The survey showed that the prevalence of hypertension 
in 2000 was 26% of the adult population globally and that in 2025 would increase by 
24% in developed countries and 80% in developing countries.79 Despite the development 
of new medications to treat hypertension, adequate treatment continues to be a problem 
in major part of  the globe. The prescribing pattern of drugs used to treat hypertension 
changes over time in response to changes in recommended guidelines and innovations in 
drug formulations. In addition, the classes of antihypertensive drugs used vary among 
the countries. The overall rate of successful blood pressure control is low among 
hypertensive patients receiving treatment, and despite the inadequacy of certain drugs , 
many of the patients continue the same treatment regimen.83      
                                     With repeated BP recordings during admission and followup and 
with investigations like ECG and Echo it has been confirm ed that all the patients in our 
study had hypertension. Nonetheless, only 43% of them had their hypertension detected 
before the ictus and in them blood pressure control was inadequate in many instances. 
This clearly indicates that undetected and undertreated  hypertension is the most 
important risk factor for spontaneous ICH. This is consistent in the previous studies 
which have concluded that Hypertension remains the single most important target for 
ICH prevention, the odds ratio for ICH is 3.5 for untreated hypertension but only 1.4 for 
treated hypertension and the treatment of hypertension can prevent ICH (class I).68 
Therefore it becomes imperative to detect hypertension in the asymptomatic population 
and devise pharmacologic and nonpharmocologic treatment modalities for long term 
management of hypertension.According to a study performed by Thakkappan  and   co 
workers the overall prevalence of hypertension was 36.7% in southern part of India.81 
Hypertension is directly responsible for 57% of all stroke deaths in India.8o  A declining 
trend in the incidence of ICH has been reported from Hisayama, Japan where it was also 
related to a decrease in the frequency of hypertension.69
             The autopsy study of McCormick and Rosenfield challenged the view that 
hypertension represents the main causative factor in ICH.70 Their series included a large 
number of cases of ICH due to blood dyscrasias, vascular malformation and tumours and 
hypertension was regarded as the sole basis for bleeding in only 25%  of the total. This 
discrepancy with some reported series of  ICH may reflect in them part of referral 
pattern bias, as well as more stringent criteria in establishing a causal relationship 
between hypertension and ICH. However, with other popular studies, the role of 
hypertension as a leading risk factor is well established and its frequency has been 
estimated to be between 72% and 81%.71 The causative role of hypertension is supported 
by the high incidence of left ventricular hypertrophy in autopsy cases of ICH and the 
significantly higher admission blood pressure readings in ICH patients compared with 
those with other forms of stroke.72 
                                                 The guidelines for the management of acute ICH 
published by the Special Writing Group of the Stroke Council and the American Heart 
Association,  acknowledge the absence of systematic overviews and randomised 
interventional trials. They, however, recommended treatment of hypertension as the 
most effective means to prevent primary ICH and its associated morbidity and mortality. 
Many studies have identified hypertension as a major risk factor for the development of 
primary and recurrent ICH. Chronic hypertension (HTN) is the most important risk 
factor for ICH and is responsible for almost 60% of cases.39,40,41 The strength of 
association between BP and haemorrhagic stroke appears to be greater than that 
observed for ischaemic stroke. A study on 17 cohorts from the People's Republic of 
China and Japan   involving 115 757 participants showed a significantly stronger 
association of usual diastolic BP with haemorrhagic stroke than with nonhaemorrhagic 
stroke, and the odds ratio for 5 mmHg lower BP was 0.54 [95% CI, 0.50–0.58] vs 0.61 
[95% CI, 0.57–0.66] for haemorrhagic and ischaemic stroke, respectively. 
                                Elevated blood pressure is common acutely after ICH, even in 
patients  without a prior history of HTN57,58,59. In most cases, blood pressure 
spontaneously declines over 7 to 10 days, and the maximal decline occurs  over the first 
24 hours60.
                                                   In cohorts from Japan and the People's Republic of 
China according to usual diastolic BP (Eastern Stroke and Coronary Heart Disease 
Collaborative Research Group, 1998), logistic regression analyses showed a stronger 
association of usual diastolic BP with haemorrhagic stroke than with nonhaemorrhagic 
stroke (OR for 5 mmHg decrease 0.54 CI: 0.50–0.58, vs 0.61 CI: 0.57–0.66, P for 
heterogeneity 0.02). (The Lancet, 1998; 352: 1801–1807).
                                                                With regard to haemorrhagic stroke there is a 
mechanism of action plus evidence that blood pressure reduction can prevent the risk of 
stroke.82 It is well established that hematoma expansion in spontaneous ICH occurs 
within the first 24 hours after ictus in about one third of patients48.49. Hematoma volume 
and hematoma expansion are predictors of 30-day functional outcome and 
mortality48,50.51. A direct relationship between blood pressure and risk of hematoma 
enlargement has been shown in some studies,  but  others  do not  support   this 
association52,53,54. It is also unclear if high blood pressure is the cause or a hemodynamic 
response to the growing hematoma54.
                             The Systolic Hypertension in the Elderly Program (SHEP) Study 
determined the effects, on stroke, of treating isolated systolic hypertension in 4736 
elderly patients. Antihypertensive treatment appears to be more protective against 
haemorrhagic stroke than ischaemic stroke, the relative risk reduction for haemorrhagic 
stroke being 0.46 (95% CI: 0.21–1.02) compared to 0.63 (95% CI: 0.48–0.82) for 
ischaemic stroke. Treatment benefits were also reported to appear earlier for 
haemorrhagic stroke compared to ischaemic stroke, observed within 1 year for 
haemorrhagic stroke but not until the second year for ischaemic stroke. However, the 
number of patients with haemorrhagic stroke was only 28.
                   High BP has also been shown to be an important risk factor for the 
recurrence of ICH. In a prospective study of 74 patients with hypertensive brain 
haemorrhage, higher diastolic BP was related to an increased rate of rebleeding. 
Recurrence rate was calculated to be 10.0% per patient-year among individuals with 
diastolic BP>90 mmHg and <1.5% in those with lower diastolic BP. A retrospective 
study of 51 patients with previous ICH also showed the stroke recurrence rate to be 
lower in a group with post-stroke BP<80 mmHg compared to those with post-stroke BP 
>90 mmHg.
                                            The recently reported Perindopril Protection Against 
Recurrent Stroke Study (PROGRESS) investigated the effects of BP lowering with an 
angiotensin-converting enzyme (ACE) inhibitor-based regimen in patients with a history 
of cerebrovascular disease. Compared with placebo, treatment with the ACE inhibitor, 
perindopril, with the addition of a diuretic, indapamide, in 58% of subjects, resulted in a 
significant 28% (95% CI: 17–38) reduction in the occurrence of all stroke. Treatment 
appeared to offer greater protection against haemorrhagic stroke, reducing risk by 50% 
(95% CI: 26–67) compared to ischaemic stroke, which reduced risk by 24% (95% CI 
10–35). The role of BP in the prognosis and major complications of acute ICH and 
optimal management of BP in the early stages of acute ICH is still unclear. 
                            
             Abott et al showed an increased risk of intracerebral haemorrhage in cigarette 
smoking Hawaiian men of Japanese ancestry. The risk of haemorragic stroke was 2.5 
times higher in smokers, an effect that is independent of other risk factors. However, the 
diagnosis of  ICH  was often made on clinical grounds without verification by imaging 
or autopsy findings.In a recent study on computed tomography diagnosis of ICH in 
Finland, Juvela et al found that smoking was not independent for ICH. In our study too, 
only 28% of the patient were found to be smokers and and in none of the patients with 
ICH, smoking was an isolated risk factor. Similarly the incidence of diabetes mellitus in 
our study was only 15% indicating that DM is a less important risk factor for ICH 
compared to untreated hypertension.
            Excessive alcohol consumption is associated with increased risk of  ICH  and 
should be discouraged (class II).68 The series reported by Donaline et al and Juvela et al 
documented an increased risk of ICH in relation to alcohol ingestion, an effect that 
operated independently from other risk factors. Both studies showed a strong dose – 
response relationship between alcohol use and ICH.Alcohol induced hypertension 
predisposes to spontaneous intracerebral haemorrhage.93 The series of Juvela et al 
documented a similar effect for alcohol ingestion within 24 hrs from ICH onset and 
within 1 week from onset.90 
                                In our study, 47% of patients had given H/o regular alcohol 
consumption, making alcohol ingestion a single predominant avoidable risk factor for 
ICH. In addition, those who consumed alcohol within 48hrs preceding the ictus was 
32% which again is a significant figure statistically. Among the 69 patients who had a 
good outcome among the 231patients in our study,only 21(30%) had had an alcoholic 
binge in the preceding 48 hours and 48(70%) had been sober in that period.Most 
importantly, among the 57 patients who died in the study , 27 (47.4%) of them had 
consumed alcohol within 48hrs of the ictus making it clear that alcohol ingestion not 
only increases the incidence of ICH but also mortality, especially in those with a recent 
binge.
              Clinical features of ICH associated with increased ICP are headache and 
vomiting. Although they vary greatly in their frequency, depending on the location of 
the haemorrhage, their overall importance at the onset of ICH is limited.91 Of the 54 
patients alert enough to report the symptom, only 36% reported headache in the series of 
Mohr et al. Aring’s  series disclosed a frequency of headache of 23%. The reporting of 
vomiting at onset follows similar frequencies of 44% and 22% in these two series. In our 
study, headache was reported by 44% of patients, vomiting by 56% and both headache 
and vomiting by 35%. These findings stress the important clinical point that absence of 
headache and vomiting does not rule out ICH.89 On the other hand, when present, these 
signs suggest ICH as the most likely diagnosis, since occlusive strokes show them in 
less than 10% of cases.88 This corresponds to the conclusion of  Mohr, Caplan, and 
Melski (1978) regarding significance of  headache and vomiting in the diagnosis of ICH.
              Seizures at the onset of ICH is uncommon.88 They have been reported at the 
rates as low as 7%, 11% and 14% in the studies of Mohr, Furlan, and Aring respectively, 
when all forms of ICH is considered together. In some groups such as in those with 
lobar haemorrhages, according to Kase, Willams, and Wyatt et al, seizures have been 
reported in as many as 32% of patients. In our study interestingly almost similar figures 
are seen i.e. the overall incidence is about 13% and the incidence of seizures in Lobar, 
putaminal, thalamic and infratentorial locations of haemorrhage, are 30%, 16%, 5%, and 
0% respectively. Another interesting observations in our study is that almost all patients 
of putaminal haemorrhage who had seizures had fairly large haematomas with volume 
being in excess of 40ml. Among the focal symptoms, like most previous studies, limb 
weakness was the commonest being 81% followed by speech disturbances in 57% of 
patients in our study.
                Patients with ICH frequentlyshow some degree of decreased alertness at the 
time of admission, as a consequence of increased ICP. According to Wiggins, Moody, 
Toole et al,  the frequency and severity of this sign vary to some extent according to the 
location of the haemorrhage, but when all forms are considered, it is present in atleast 
60% of the cases and in two thirds of them to the extent of being comatosed. According 
to Portenoy, Lipton and Berger et al,  coma has  correlated with ventricular extension, 
large size of haematoma and poor vital prognosis.88
                                                                                            The degree of impairment of consciousness depends on 
the location, size and extension of the haematoma ( deep structures and ventricles ) and 
some degree of altered consciousness was present in 60% of the cases reported by Mohr 
and co-workers.91 In our study, about 52% of patients presented with disturbed 
consciousness and among them all those with significant loss of consciousness had a 
poor outcome with an mRS of  5 or 6.
             According to Fisher, Picard and Polak,  ICH  occurs characteristically during 
activity and onset during sleep is extremely rare.88 It occurred in only one instance in 
Fisher’s series, and in only 3% of ICH cases included in the NINCDS stroke data 
bank( Kunitz, Gross, Heyman et al — 1984 ) . In our study, 8% of patients gave history 
of onset during sleep and another 4% on awakening. In about 63% of patient the onset 
was during activity, most of them during light activity.
             In hypertensive patients, cerebral infarction is secondary to increased 
atherosclerosis, whereas cerebral haemorrhage is the result of both elevated arterial 
pressure and the development of cerebral vascular microaneurysm . Only age and 
arterial pressure are known to influence the development of microaneuysms and rupture 
of the microaneurysms is the usual cause of hypertension associated intracerebral 
haemorrhae.84Higher levels of both systolic and diastolic blood pressure have been 
associated with an increased incidence of  haemorrhagic strokes in patients of all ages.85 
Thus it is not surprising that arterial pressure shows a better association with 
intracerebral haemorrhage than with either cerebral or myocardial infarction. In 1855, 
before blood pressure could be measured, Kirkes observed hypertrophy of the 
heart in 17 of 22 patients with fatal brain haemorrhage.63 In our study about 49% of 
patients had their admission Diastolic BP more than 100mm of Hg and about 65% of the 
patients had their systolic BP more than 160mm of Hg.In one study of 188 patients with 
primary ICH, researchers determined the cause to be hypertension in 72% of patients.93
                 The National Institute of Health stroke scale( NIHSS ) is the most commonly 
used scale for grading severity of stroke. It summarises all the impairments of stroke 
into one scale. It is simple and short. The generally accepted neurologic examination for 
stroke patients is the NIHSS, which assesses neurologic domains such as level of 
consciousness, motor, sensory, speech, and language. This standardized tool aids in 
localizing the stroke lesion and in quantifying the deficit.92 Among the 57 patients who 
died in our study, none of them had a NIHSS score of less than 16, and only 21% of had 
a score of 16 to 22 and about 79% of had a score of more than 23 indicating a very 
severe impairment. Among the 72 patients with a very severe NIHSS score, 45  (62.5%) 
died in the first month. Thus it can be inferred that NIHSS score is an indication of 
severity of the ICH and those with very severe score have about 63%  probability of 
mortality in the first month after the ictus.
                
                                                            Among those who died in the first month, none had 
an ICH score of  0, 6 (10%) had a score of 1, 12 (20%)had a score of 2 and the rest i.e. 
39 (69%)had a score of 3 or 4. This indicates that the patients with the ICH score of 0 
usually survive and the 30 day mortality increases steadily with ICH score. Thus it can 
be inferred that the ICH score is a simple clinical grading scale that allows the risk 
stratification on presentation with ICH. The use of a scale such as the ICH score could 
improve standardization of clinical treatment protocols and clinical research studies in 
ICH.
                  Spontaneous ICH occurs predominantly in the deep portions of the cerebral 
hemispheres. The haemorrhages of putaminal, thalamic, and pontine location occur in 
the vascular distribution of small perforating intracerebral arteries, lenticulostriate, 
thalomaperforating and basilar paramedian groups respectively. Cerebellar haemorrage 
occurs in the area of dentate nucleus, which is supplied by small branches of both the 
superior and the anterior – inferior cerebellar arteries. Thus most ICHs originate from 
the rupture of deep arteries, of diameters between 50 and 200mm. These same arteries 
are recognized to be those occluded in cases of lacunar infarcts, a form of stroke 
correlated with chronic hypertension. Thus, it is apparent that those various groups of 
small arteries, located in well defined anatomic areas become the target of chronic 
hypertension and the result can be either occlusion or rupture, leading to lacunar infarcts 
or ICH, respectively. 
                                         The most common location of spontaneous intracerebral 
haemorrhage is the putamen, accounting for about 35% to 50% of the cases. In our study 
too, putamen is the commonest site of ICH, the incidence being 54.5%. A biracial 
population study of 1,038 ICH cases showed that 49% were located deep in hemisphere, 
35% lobar, 10% cerebellar, and 6% in the  brain stem46. The hematoma location may be 
suggestive of the underlying  etiology. Among 100 cases of ICH at the University  of 
South Alabama Medical Centre, Kase and associates found putaminal haemorrhage in 
34, lobar haemorrhage in 24, thalamic haemorrhage in 20, cerebellar haemorrhage in 7, 
pontine haemorrhage in 6, caudate haemorrhage in 5, and putaminothalamic in 4.When 
this is compared with the frequency of ICH location in our study, it can be seen that 
except for lobar haemorrhages which are substantially less common in our study,the 
incidence regarding other locations are fairly similar. The reason may be that cases of 
ICH due to AVM, aneurysmal rupture etc. were excluded from our study. This again 
reiterates the fact that cases of   hypertensive ICH is common at deeper locations.
                                              Spontaneous intracerebral hemorrhage (ICH) is 
a neurologic emergency that accounts for about 10% to 20% of all strokes 
and has a 30-day mortality rate of 35% to 52%35,36. Furthermore, only 21% of 
patients suffering ICH are expected to be independent at 6 months 37. Despite 
advances in our understanding of the pathophysiology and complications 
associated with ICH, in-hospital mortality from ICH decreased by a mere 6% between 
1990  and  2000,  compared  with  36%  and  10%  mortality  reductions  achieved  for 
ischemic stroke and subarachnoid hemorrhage, respectively. 38Bamford et al reported a 
30 day mortality of 44 – 51% in paients with ICH, with the majority of early deaths 
occuring due to brain herniation.87   In the study of brain herniations in patients with ICH, 
by Kalita et al, out of 24 patients, 13 patients died by 1 month, with a 30 day mortality 
of  54%.86
                                    Various authors, including Bogousslavsky et al, Bozzola et al, 
Portenoy et al, and Sacco et al reported a mortality rate varying from 20% to 70%.89 
Although the mortality is strongly dependent on haematoma size and to a lesser extent, 
location, the overall mortality rate varies between 25% and 60%.93 Among the total 
number of  231 patients in our study, the number of patients who died ( mRS of 6 ) in 
the first month is  57  ( 25% ) and those who had   severe disability   ( mRs of 5 ) is   87 
(38%).  
                                         According to Flaherty et al, death at 1 year varies by location, being 
highest for brainstem at 65%, 57% for lobar, 51% for deep ganglionic, and 42% for 
cerebellar.66 The mortality rates reported for lobar haemorrhage have been between the 
extremes of  11.5%(Ropper&Davis, 1980) and 32%(Kase et al., 1982), in comparison 
with 42% basal ganglionic and thalamic ICH, and 43% for posterior fossa 
haemorrhages(Steiner et al., 1984). However in large series of patients comparisons of 
mortality  lobar  and  deep  hemisheric  ICH  have  shown  no  significant  differences 
(  Massaro et al., 1991 ).
                                 These authors reported  a 30-day fatality rate of 27.7% for patients 
with lobar haemorrhage, and 31.8% with deep haemorrrhages.These differences in 
mortality among series of  lobar and deep ICH may reflect vaiation in haematoma size 
and mass effect more than superficial vs. deep location.73  In our study, 30 day mortality 
is highest for cerebellum at 66%, 50% pons, 26% at putamen, 17% at lobar, 10% at 
thalamus,and 0% at caudate nucleus,reflecting the fact that the prognosis is worse for 
infratentorial ICH compared to the supratentorial haematomas.
                                         In 1961 McKissock and colleagues reported the first 
randomized, prospective, controlled trial which suggested that surgical evacuation was 
not beneficial for treating ICH. In total, 12 prospective randomized trials have 
investigated the role of surgical evacuation in the treatment of ICH. In summary, these 
results have shown that surgery does not significantly improve outcomes when 
compared with medical therapy alone. In 2005 the landmark Surgical Trial in 
Intracerebral Hemorrhage (STICH) study prospectively examined the role of surgery in 
1033 patients. Surgical clot removal within 24 hours of spontaneous supratentorial ICH 
was of no significant benefit however, the STICH results must be interpreted with 
caution because high crossover from the medical group to surgery (140 out of 530 
patients) and the lack of clinical equipoise regarding surgical
evacuation of large lobar hematomas and nondominant hemisphere hematomas leading 
to nonrandomization into STICH may have resulted in bias favoring medical treatment . 
A meta-analysis examining mortality in these 12 studies reported 392 of 1182 (33%) 
deaths in the medical group versus 346 of 1183 (29%) in the surgical group. Although 
no statistically significant benefit can be attributed to surgical treatment, the trend 
favoring surgery is seen despite imminently herniating and deteriorating patients being 
excluded from the trials. Although the preponderance of evidence suggests that routine 
surgical evacuation of supratentorial hematomas is not superior to medical treatment 
alone, surgery may be beneficial in a subset of patients.78
              Putaminal haemorrhage is the most common form of ICH and can manifest in 
different ways, depending on the size and extent of the haematoma.89 Dense neurological 
deficits associated with coma usually suggest large haematomas and are associated with 
a poor prognosis. Intraventricular extension also implies extensive parenchymal 
dissection or destruction.94 Patients who present with partial motor deficits, an alert 
neurological status, normal extraocular movements, full visual fields, and no lateral or 
upward extension of the haematoma have a better prognosis on the basis of reversible 
compression of capsular fibres, as the internal capsule is either displaced medially or 
directly involved by the haematoma.Modern CT series of putaminal haemorrhage 
document a mortality rate of  37%, in contrast to 65% to 75% from pre CT era. This 
difference reflects the description of the full spectrum of haematoma size in recent 
reports, including benign haematomas with benign outcomes, which were misdiagnosed 
as infarcts in the pre CT era.93 In our study, we have come across putaminal 
haemorrhages of various sizes ranging from 0.75ml to 144ml. On analyzing the outcome 
with respect to volume it is evident that the morbidity and mortality steadily increase 
with increasing volume of ICH, with all the 9 patients with a volume of more than 
100ml dying in the first month. Among 126 patients with putaminal haemorrhage, 48 
had ventricular extension, all with volumes more than those with no IVH,and with worse 
outcome with 50% dying in the first month and another 50%  being left with severe 
disability. These factors are consistent with the earlier observation of Hier, Davis, 
Richardson and Mohr et al  that a putaminal haematoma that directly extends into the 
ventricle is usually of large size and  is associated with high mortality.94
                        The thalamic form of ICH accounts for 10% to 15% of parenchymatous 
haemorrhage ( Walshe, Davis and Fisher et al, 1977 ).88 Compared to similar earlier 
studies, the incidence of thalamic haemorrhage is more in our study, being 26% versus 
15%, the reason being the relative absence of nonhypertensive etiologies in our patients. 
Thalamic haemorrhages of various volumes have been encountered, with the smallest 
being 0.5ml and the largest 24ml. Compared to putaminal haemorrhages, thalamic 
haematomas are relatively smaller with 45% of them being smaller than 5ml and 90% of 
them smaller than 20ml, but more than 47% of putaminal haemorrhages are larger than 
20ml. The reason for this difference may be that about 60%  of the thalamic 
haemorrhages are  associated with IVH with partial decompression of thalamic 
haematomas into the ventricles because of which the true intraparenchymal volume 
cannot be assessed easily. 
                                                          Though larger haematomas are associated with 
poorer outcome, it is not strictly linear as can be seen from the fact that the 6 patients 
with thalamic haematoma who died, had a volume of 11 to 20ml and none with the 
volume larger than 20ml died in the first month.Similar observation was made by 
Piepgras and Rieger who described two patients in their series who survived  with 
haematomas of  more than 4 cm diameter.95Small and moderate-sized hemorrhages that 
rupture into the third ventricle have been associated with fewer neurologic deficits and 
better outcomes.3
                                                          Similarly presence or absence of IVH in thalamic 
haematomas does not clearly predict the prognosis.According to Qureshi, Safdar, Weil 
et al who reviewed 182 African American patients in 1995, an ICH volume of greater 
than 30 ml and ventricular extension are independent predictors of early deterioration 
and death. This fact which holds good for our patients of putaminal ICH, interestingly 
can not be applied to our patients with thalamic ICH for reasons already quoted. This 
observation assumes significance when  surgery is contemplated in a patient with 
thalamic ICH.
                                            
                  The pons is the most common location for nonvascular causes of ICH in the 
brainstem. Spontaneous nontraumatic midbrain and medullary haematomas are rare.89 
Fang and Foley and later Dinsdale reviewed the necropsies at Boston City Hospital and 
found  511  ICHs among 19,093 autopsies, of which 30 were pontine ( 6% ).In our study 
,similarly, pontine haemorrhage comprised 5.2 % of ICH cases.  In the aforementioned 
review of 30 cases of pontine haemorrhages among 511 cases of  ICH  , two thirds of 
patients were comatose on presentation and had  massive haemorrhages that extended 
into midbrain or fourth ventricle. Within 48hrs 78% of patients had died. 
                                                   As per Steegmann and others, massive pontine 
haemorrhages are always fatal and some patients with medium sized haematomas and 
most patients with small or segmental haematomas survive, with various degree of 
residual neurological deficits.89In a series of 60 patients with pontine hemorrhage 
reviewed by Nakajima, 19 survived (8 of whom had remained alert). Similarly, Wijdicks 
and St. Louis reported that 21 percent made a good recovery—mostly those who were 
awake on admission.3 In our study, all the 6 patients with pontine haematomas of volume 
less than 5ml survived with an mRS of  3  and all those with a volume of more than 5ml 
died earlier, with 50% of them with and 50% of them without IVH. Therefore it can be 
inferred that with regard to pontine haematoma, it is the volume of  haematoma  and  not 
the presence or absence of IVH that predicts the outcome.
                Cerebellar haemorrhage appear with a frequency variously quoted as between 
5% and 15% and average frequency is about 10% approximating the relative percentage 
of weight of the cerebellum in reference to the entire brain.88 But according to Dinstale 
and Freeman, the frequency of cerbellar haemorrhage ranges between 5% and 10%. In 
our study, it is only 4%. In the series the Fisher et al , the left hemisphere was affected 
twice as often as the right. Mckissock et al also commented on a left cerebellar 
predominance. Most other series do not report haemorrhage laterality. Similarly, in our 
study the right cerebellar hemisphere has been involved twice as often as the left.
                          The clinical course in cerebellar haemorrhage is notoriously 
unpredictable; patients who are alert or drowsy on admission can deteriorate suddenly to 
coma and death without warning, while others in a similar clinical status have an 
uneventful course with complete recovery of function. Of those patients who were not 
comatose on admission, only 20% had a smooth, uneventful recovery in the series of Ott 
et al, whereas 80% deteriorated to coma, one-fourth of them within 3 hours from the 
onset.96 A similar frequency was observed in the series of Fisher et al, where only 2 of 18 
patients had a benign course, the other 16 deterirating to coma at variable intervals, 
mostly within few hours after onset. Although most cases deteriorate early in the course, 
occasional patients have shown fatal decompensations at a later state, even a month 
later, although they were stable in the interim.                 
 
                                           Since prediction of clinical course cannot be made based on 
clinical parameters on admission, the recommendation followed that surgical evacuation 
of the hematoma should be undertaken whenever the diagnosis is made within 48 hours 
from the onset. The need for prompt diagnosis and emergency surgery had its 
justification in the documented poor surgical outcome with worsening preoperative 
mental status, the surgical mortality being 17% for responsive and 75% for unresponsive 
patients. These figures have proved generally accurate, despite occasional reports of 
good surgical results in comatose patients. The use of CT scan in cerebellar 
haemorrhage has permitted the recognition of many different aspects of these lesions, 
some of which are useful early predictors of clinical course.89 
               Little and collegues reported two groups of patients with cerebellar 
haemorrhage. The first group presented with an abrupt onset, progressive course and low 
level of consciousness. CT in this group of patients showed cerebellar haematomas 3cm 
or greater in diameter, obstructive hydrocephalus and extension of haemorrhage into the 
fourth ventricle. The second group of patients was awake and stable and had 
haematomas smaller than 3cm in diameter. They had good outcome.  As a rule, a 
cerebellar hematoma less than 2 cm in diameter leaves most patients awake and 
infrequently leads to deterioration, therefore generally not requiring surgery. 
Hematomas that are 4 cm or more in largest diameter, especially if located in the vermis, 
pose the greatest risk, and some surgeons have recommended evacuation of lesions of 
this size no matter what the clinical status of the patient.3 Similar results were obtained 
in our study too with 3 patients with volume of less than 10ml having a good outcome of 
mRS score of 2 and all the 6 patients of haematoma volume of 10 to 20ml dying in the 
first month. Interestingly, in our study all the 3 patients who survived did not have IVH 
and all the 6 patients who had larger volume and consequently ventricular extension 
died in the first month. Therefore it can be inferred from our study that a volume of 
more than 10ml and intraventricular extension are indicators of  bad prognosis in 
cerebellar haemorhage.
              According to Ropper et al, the prognosis of  lobar ICH  is relatively better than 
that of other forms of ICH and mortality ranges from 11% to 29%. According to Helweg 
et al, the functional outcome for survivors of lobar haemorrhage also tends to be better. 
In our study also, the 30 day mortality of Lobar haemorrhage is only 16.7% compared to 
cerebellar, pontine and putaminal haemorrhages with 66%, 50% and 26% respectively.
          In their series of 22 patients Kase and associates reported good outcomes in those 
with haematoma volumes less than 20 cm3,70% survived after the surgical removal of 
haematomas that were 20 to 60 cm3. No patient with a haematoma volume greater than 
60cm3 survived. Similar to these studies, among our patients too, all those who died in 
the first month had  Lobar haematoma of volume more than 20ml and the outcome mRS 
was proportionate to the volume of haematoma. 
                                                   With respect to ventricular extension, in contrast to other 
locations, patients with  Lobar haematomas  and   IVH   had a better outcome compared 
to those with  no  ventricular extension.  The probable reason for this observation is that 
all the three patients with  lobar ICH with IVH   had small haematomas of volume less 
than 5ml but in close proximity to the lateral ventricle. This conforms to the 
observations of Kase et al according to whom ventricular extension in patients with 
lobar ICH was a factor that correlated with location              ( proximity to ventricular 
system ) rather than size of the haematoma.88
            According to Stein and associates caudate haematoma represents approximately 
5% to 7% of cases of ICH, the bleeding vessels being the perforating branches of the 
anterior and middle cerebral arteries.75 The outcome of patients with caudate 
haemorrhage is so excellent that more than 80% of patients return to normal activities 
and less than 20% of patients remain slightly hemiparetic with death being rare ( Chung 
et al 2000 ).76 
                                                                          In our study, the incidence of caudate haematoma is as low as 
3% only. With respect to volume, those with volume <5ml had complete recovery and 
those with larger haematoma of volume >5ml had a significantly worse outcome with an 
mRS of 5. Another very interesting observation in our study is that all the six patiets had 
ventricular extension and none died in the first month, probably indicating that 
ventricular extension serves as a natural decompressive mechanism with respect to 
caudate haematoma,making the prognosis excellent for caudate haemorrhage,especially 
with regard to mortatity.
                                           
                                          
                                                  CONCLUSION
1.Males predominate among patients of  ICH with a ratio of 5:2.,the  male 
predominance is probably attributable to the high prevalence of  alcohol among males.
2.Hypertension is the most important causative factor for ICH.
3.Alcohol ingestion not only increases the incidence of  ICH but also the mortality, 
especially in those with a recent binge.
4.Among patients of ICH, headache is reported by 44% of patients, vomiting by 56% 
and both headache and vomiting by 35%.
5.Patients presenting with significant loss of consciousness have a poor outcome with an 
mRS of   5 or 6.
6. NIHSS score is an indication of severity of the ICH and those with very severe 
score( >22 ) have about 63%  probability of mortality in the first month after the ictus.
8. Patients with the ICH score of  0 usually survive and the 30 day mortality increases 
steadily with ICH score.
9.The frequency of ICH location is as follows : Putamen- 54.5% ; Thalamus-25.9% ; 
Lobar ICH- 7.8% ; Pons- 5.2% ; Cerebellum – 3.9% ;  Caudate nucleus- 2.6% .
10.Almost all patients of putaminal haemorrhage who had seizures have fairly large 
haematomas with volume being in excess of 40ml and consequently a poorer outcome.
Putaminal haemorrhage is the most common form of ICH and a putaminal haematoma 
that directly extends into the ventricle is usually of large size and  is associated with high 
mortality.
 11.Though larger thalamic haematomas are associated with poorer outcome, it is not 
strictly linear. Similarly presence or absence of  IVH  in thalamic haematomas does not 
clearly predict the prognosis.With regard to pontine haematoma,it is the volume and not 
the presence or absence of  IVH that predicts the outcome but a volume more than 10 ml 
and intraventricular extension are indicators of bad prognosis in cerebellar haemorrhage. 
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                                 PROFORMA
               NAME :                                                 AGE :            SEX :
UNIT :                                 IP NO :                          MIN NO :
ADDRESS/PHONE NO :
DATE OR ENTRY :
  
Date and time of ictus :
            Date and time of admission :
   In any centre:
  In our centre:
              Arrival time in EMD after ictus : ½ hr (    ); 1-2hrs (    ); 2-3 hrs (    );
    3-6 hrs (    ); 6-12 hrs (    ); 12-24 hrs (    );  24-48 hrs (    ); after 2 days (    )
              Educational status : pri sch (    ); sec sch (    ); U.G (    ); P.G (    );
    Professional (    ); uneducated (    )
Religion :Hindu (    ); Muslim (    ); Christian (    ) others (    )
Income : Low (    ); Middle (    ) ; High (    )
Relevant medical conditions :
    DM :
    HT :
Habits   :           Ethonal :
                      Smoking :
Symptoms at onset : Headache (    ); vomiting (    ); LOC (    ); Seizures (    )
                 Limb weakness (    ); speech distur (    ); sensory loss (    );visual distur (    )
               Activity when symptoms noticed first : sleep (    );on awakening (    );
                           While rest (    ); light activity (    );Heavy exertion (    );others (    )
H/O Bleeding Disorder/Anticoa/Antipl/Th.lytic :
Pulse/BP :                           RR:                ;Temp:             ;BMI:
CVS,RS,Abd,Others/bleeding :
GLASGOW COMA SCALE :
EYE OPENING :___________ 4 spontaneous; 3 To voice; 2 To pain; 1 None
            VERBAL RESPONSE :__________ 5 Normal conversation; 4 Disoriented 
            conversation 3 words coherent; 2 no words…only sounds; 1 none                          
                               
MOTOR RESPONSE :_________ 6 Normal; 5 Localizes to pain; 4withdraws to pain; 
3 Abnormal flexion; 2 Abnormal extension; 1 None 
NIHSS :
            
         
               1a Level of conciousness :__________
0 Alert                1 Drowsy                     2 stuporous              3 comotose
1b LOC Questions :_________ (Month/Age)
0 Both correct               1 one correct            2 Incorrect
1c LOC commands :____________(open,closeeyes,make fist,let go )
0 obeys both correctly               1 obeys one correctly       2 Incorrect
               2 Best gaze :____________ 
              (eyes open patient follows examiner’s finger or face)
0 Normal                 1 partial gaze palsy            2 Forced deviation
3 visual:____________
(introduce visual stimulus/threat to patient’s visual quadrants)
0 No loss                  1 partial hemianopia               2 complete hemianopia
3 Bilateral hemianopia
4 Facial palsy : ____________(show teeth,raise eyebrows and squeeze eyes shut) 0 
Normal 
1 minor asymmetry       2 partial(lower face paralysis) 3 complete
5a  Motor  Arm-Left  :____________(Elevate  extremity  90deg  and  score 
drift/movement) 
0 drift                 1 drift              2 some effort against gravity            3 No effort against 
gravity             4 no movement          9 amputation,joint fusion
5b Motor Arm-right :___________
(Elevate extremity 90deg and score drift/movement)
0 No drift                      1 drift                     2 some effort against gravity
3 No effort against gravity          4 No movement        9 Amputation,joint fusion
6a Motor leg-left :____________
(Elevate extremity 90deg and score drift/movement )
0 No drift                  1 drift                 2 some effort against gravity
3 No effort against gravity             4 No movement           9Amputation,joint fusion
 
6b motor leg-right :__________
(Elevate extremity 90deg and score drift /movement)
0 No drift               1 drift                    2 some effort against gravity
3 No effort against gravity          4 No movement              9 Amputation,joint fusion
7 Limb ataxia :_____________
0 Absent                    1 present in upper or lower          2 present in both
8 sensory :____________
(pin prick to face,arm trunk and leg compare side to side)
0 Normal                    1 partial loss              2 Dense loss
9 Best language :____________
(Name items,describe a picture and read sentences)
0 No aphasia         1 Mild-moderate aphasia           2 severe aphasia       3 Mute
10 Dysarthria:____________
(Evaluate speech clarity by patient repeating listed words)
0 Normal articulation                   1 Mild-moderate slurring
2 severe,nearly intelligible               9 Not scored
11  Extinction  and  Inattention  :___________(use  information  from prior  to  testing 
identify 
neglect or double stimuli testing )
0 No neglect                1 partial neglect           2 profound neglect
                MODIFIED  RANKIN SCALE :_________    
0 =  No symptoms at all
1 = No significant disability despite symptoms; able to carry out all usual duties and 
activities
2 = slight disability; unable to carry out previous activities, but able to look after own
 affairs without assistance
3 = moderate disability; requiring some help, but able to walk without assistance
4 =  moderately  severe  disability;  unable  to  walk  without  assistance  and unable  to 
attend to
 own bodily needs without assistance
5 = severe disability; bedridden, incontinent and requiring constant nursing care and 
attention 
6 = dead 
ICHSS:___________
GCS score : __________
0 = GCS 13 – 15               1 = GCS 5 – 12               2 = GCS 3-4
ICH volume cm^3:_________
0  less than 30                                 1 greater than 30
IVH:__________
0 No                                     1 Yes 
            
Age / year : ____________
0 less than 80                                    1 greater than 80
Time interval between onset of ictus and first CT scan:
Less than ½  hr (    ); 1 – 2 hrs (    ); 2-3 hrs(    ); 3-6 hrs(    ); 6 -12 hrs(    ); 
12 – 24 hrs(    ); 24 – 48 hrs(     ); greater than 48 hrs(    )
Time interval between the first and second CT scan:
Less than ½ hr (    ); 1-2 hrs(    ); 2- 3 hrs(    ); 3 – 6 hrs(    ); 6 – 12 hrs(    )
12 – 24 hrs(    ); 24 – 48 hrs(    ); greater than 48 hrs(     )
CT Findings :
ICH (location, volume, PH,oedema) /  IVH (Volume)
rFVII  Treatment/  surgery/  conservative  treatment/Inhospital 
complications/Investigations :
                EGOSS :___________
1 Dead; 2 veg state;3 lower sev dis; 4 upper sev dis; 5 lower mod dis;  
6 upper mod dis; 7 lower good rec; 8 upper good rec 
(sev-severe;mod-moderate;dis-disability;rec-recovery)
GUY’S HOSPITAL, SCORING SYSTEM (ALLEN):________________
VARIABLE                         CLINICAL FEATURE                       SCORE
1.   APOPLECTIC ONSET      
    a.LOC
    b.Headache                                  one or none                                 0
    c.vomiting                                    Two or more                              +21.9
    d.Neck stiffness                                                                                       
2. LEVEL OF CONCIOUSNESS  
                                                             Alert                                         0
                                                             Drowsy                                    +7.3
                                                             Unconscious                            +14.6
3.PLANTER RESPONSE 
                                                              Both flexor/single
                                                              extensor                                  0
                                                              Both extensors                       +7.1
4.DIASTOLIC B.P.                              B.P In mmof Hg                    +(B.P.x 0.17)
 (24hrs after admission)
5.ATHEROMA MARKERS
  (claudication, Angina,                        None                                       0
    diabetes history)                               one or more                            -3.7
6.HISTORY OF HYPERTENSION    Not present                             0
                                                              present                                    -4.1
7.PREVIOUS EVENT                          None                                      0
 (TIA,Stroke)                                         any number                           -6.7
8.HEART DISEASE                              None                                     0
                                                               Each one                               -4.3
                                                               Constant                               -12.6
(Heart diseases-a valvular murmur, cardiac failure, cardiomyopathy, atrial fibrillation, 
cardiomegally and a recent myocardial infarction)
                                          
                                                    
   
